Investors await crucial bone drug data from Amgen - guardian.co.uk
Investors await crucial bone drug data from Amgen guardian.co.uk, UK - 3 minutes ago Merck scientists were not immediately available to comment on the potential long-term side effects of Fosamax, which is now also available in generic ...